Radiopharm Theranostics Limited Stock Market Value
| RADX Stock | 4.49 0.13 2.81% |
| Symbol | Radiopharm |
Radiopharm Theranostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Radiopharm Theranostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Radiopharm Theranostics.
| 08/23/2025 |
| 11/21/2025 |
If you would invest 0.00 in Radiopharm Theranostics on August 23, 2025 and sell it all today you would earn a total of 0.00 from holding Radiopharm Theranostics Limited or generate 0.0% return on investment in Radiopharm Theranostics over 90 days.
Radiopharm Theranostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Radiopharm Theranostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Radiopharm Theranostics Limited upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 34.19 | |||
| Value At Risk | (7.46) | |||
| Potential Upside | 7.44 |
Radiopharm Theranostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Radiopharm Theranostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Radiopharm Theranostics' standard deviation. In reality, there are many statistical measures that can use Radiopharm Theranostics historical prices to predict the future Radiopharm Theranostics' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.58) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Radiopharm Theranostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Radiopharm Theranostics Backtested Returns
Radiopharm Theranostics maintains Sharpe Ratio (i.e., Efficiency) of -0.0419, which implies the firm had a -0.0419 % return per unit of risk over the last 3 months. Radiopharm Theranostics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Radiopharm Theranostics' Coefficient Of Variation of (1,189), variance of 28.78, and Risk Adjusted Performance of (0.05) to confirm the risk estimate we provide. The company holds a Beta of 0.8, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Radiopharm Theranostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Radiopharm Theranostics is expected to be smaller as well. At this point, Radiopharm Theranostics has a negative expected return of -0.22%. Please make sure to check Radiopharm Theranostics' treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Radiopharm Theranostics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.57 |
Good reverse predictability
Radiopharm Theranostics Limited has good reverse predictability. Overlapping area represents the amount of predictability between Radiopharm Theranostics time series from 23rd of August 2025 to 7th of October 2025 and 7th of October 2025 to 21st of November 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Radiopharm Theranostics price movement. The serial correlation of -0.57 indicates that roughly 57.0% of current Radiopharm Theranostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.57 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 1.11 |
Radiopharm Theranostics lagged returns against current returns
Autocorrelation, which is Radiopharm Theranostics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Radiopharm Theranostics' pink sheet expected returns. We can calculate the autocorrelation of Radiopharm Theranostics returns to help us make a trade decision. For example, suppose you find that Radiopharm Theranostics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Radiopharm Theranostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Radiopharm Theranostics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Radiopharm Theranostics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Radiopharm Theranostics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Radiopharm Theranostics Lagged Returns
When evaluating Radiopharm Theranostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Radiopharm Theranostics pink sheet have on its future price. Radiopharm Theranostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Radiopharm Theranostics autocorrelation shows the relationship between Radiopharm Theranostics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Radiopharm Theranostics Limited.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Radiopharm Pink Sheet Analysis
When running Radiopharm Theranostics' price analysis, check to measure Radiopharm Theranostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Radiopharm Theranostics is operating at the current time. Most of Radiopharm Theranostics' value examination focuses on studying past and present price action to predict the probability of Radiopharm Theranostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Radiopharm Theranostics' price. Additionally, you may evaluate how the addition of Radiopharm Theranostics to your portfolios can decrease your overall portfolio volatility.